The use of vasoconstrictors in patients with liver cirrhosis: how, when, why
Explore this paper's citation graph
Summary
This review is aimed at addressing the role of vasoconstrictor treatment in patients suffering from complications of decompensated cirrhosis, offering practical suggestions for the management of this treatment at bedside.
- Type
- article
- Published
- 2012-09-15
- Cited by
- 1
- References
- 72
- Access
- Open access
- OpenAlex
- https://openalex.org/W1499967405
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:59140201
Keywords
Terlipressin, Medicine, Hyperdynamic circulation, Hepatorenal syndrome, Cirrhosis
References
- Systematic review of HVPG measurement: statistics versus clinical applicability.
- Long-term terlipressin administration improves renal function in cirrhotic patients with type 1 hepatorenal syndrome: a pilot study.
- Steatosis and portal hypertension.
- An Open Label, Pilot, Randomized Controlled Trial of Noradrenaline Versus Terlipressin in the Treatment of Type 1 Hepatorenal Syndrome and Predictors of Response
- Hepatic venous pressure gradient measurement: time to learn!
- EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis.
- Refractory ascites: pathogenesis, definition and therapy of a severe complication in patients with cirrhosis
- Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: A meta‐analysis
- Wedged hepatic venous pressure adequately reflects portal pressure in hepatitis C virus–related cirrhosis
- Terlipressin: An Asset for Hepatologists!
- The clinical use of HVPG measurements in chronic liver disease
- Hepatic venous pressure gradient: To measure or not to measure, that is the question
- The paradox of nitric oxide in cirrhosis and portal hypertension: Too much, not enough
- The hepatic venous pressure gradient: Anything worth doing should be done right
- Hepatic venous pressure in practice: how, when, and why.
- Hepatic venous pressure gradient determination in patients with hepatitis C virus-related and alcoholic cirrhosis
- Prevention and Management of Gastroesophageal Varices and Variceal Hemorrhage in Cirrhosis
- Efficacy and safety of terlipressin in cirrhotic patients with variceal bleeding or hepatorenal syndrome
- Terlipressin infusion induces Tako-Tsubo syndrome in a cirrhotic man with hepato-renal syndrome
- Hepatic endothelial dysfunction and abnormal angiogenesis: new targets in the treatment of portal hypertension.
Cited by
Related papers
- Terlipressin in hepatorenal syndrome: Evidence for present indications
- Pathogenesis of portal hypertension.
- Recent advances in our understanding of hepatorenal syndrome
- Terlipressin and hepatorenal syndrome: what is important for nephrologists and hepatologists.
- Effect of terlipressin on blood volume distribution in patients with cirrhosis
- HMR 1402 EFFECTS ON HEPATO-SPLANCHNIC HEMODYNAMICS AND METABOLISM DURING HYPERDYNAMIC PORCINE ENDOTOXEMIA.: 52
- Changes in systemic and splanchnic hemodynamics after orthotopic liver transplantation in cirrhotic rats.